U.S. stocks climbed on Thursday, but only after pinballing through another shaky day of trading, as Wall Street waits to see if Washington can get past its partisanship to deliver another economic rescue package.
The S&P 500 ended the day 0.5% higher. But it careened from an early 1% gain to a slight loss before arriving there. The Nasdaq composite rose a healthier 1.4%, as tech stocks again propped up the market.
Such big swings have become typical recently, as investors handicap the chances of a deal on Capitol Hill to send more cash to Americans and other aid for the economy.
On Wednesday:
The S&P 500 rose 17.80 points, or 0.5%, to 3,380.80.
The Dow Jones Industrial Average gained 35.20, or 0.1%, to 27,816.90.
The Nasdaq composite added 159.00, or 1.4%, to 11,326.51.
The Russell 2000 index of small company stocks picked up 23.51 points, or 1.6%, to 1,531.20.
For the week:
The S&P 500 is up 82.34 points, or 2.5%.
The Dow is up 642.94 points, or 2.4%.
The Nasdaq is up 412.94 points, or 3.8%.
The Russell 2000 is up 56.29 points, or 3.8%.
For the year:
The S&P 500 is up 150.02 points, or 4.6%.
The Dow is down 721.54 points, or 2.5%.
The Nasdaq is up 2,353.90 points, or 26.2%.
The Russell 2000 is down 137.27 points, or 8.2%.
Before you consider Medigus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medigus wasn't on the list.
While Medigus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report